For enterprises deploying AI applications with similar read-heavy workloads and unpredictable traffic spikes, OpenAI's ...

AI is changing the way we think about databases. You can’t have reliable AI agents without reliable data infrastructure.

Bristol-Myers Squibb has signed another deal to build its capabilities in antibody-drug conjugates for cancer, paying $100 million upfront to take control of an Orum Therapeutics candidate with a ...